Table 1.
Baseline characteristics of 80 patients with anti-interferon-γ autoantibodies.
Fig 1.
Distribution of 194 proven opportunistic pathogens diagnosed during the study period.
(Abbreviations: NTM, nontuberculous mycobacteria; VZV, Varicella zoster virus; TB, tuberculosis; MAC: Mycobacterium avium complex).
Fig 2.
Flow diagram describing the overall clinical course of 80 patients with detectable anti-IFN-γ auto-Abs.
Table 2.
Baseline characteristics compared between the drug-free remission group and the non-remission group.
Fig 3.
The distribution of optical density (OD) for anti-IFN-γ auto-Abs (median, interquartile range) taken every 3–6 months during the study period.
(A) OD in the non-remission group.(B) OD in the drug-free remission group.
Table 3.
Laboratory parameters compared between active and stable episodes for 63 patients.
Table 4.
Performance of laboratory parameters for determining active disease.